Vineet Laborator

{
  "main_header": {
    "sid": 1003496,
    "name": "Vineet Laborator",
    "stock_name": "Vineet Laborator",
    "full_name": "Vineet Laboratories Ltd",
    "name_url": "stocks-analysis/vineet-laborator",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.96",
    "chg": -0.63,
    "chgp": "-1.93%",
    "dir": -1,
    "prev_price": "32.59",
    "mcapval": "62.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543298,
    "symbol": "VINEETLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE505Y01010",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "21.22 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vineet-laborator-1003496-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Vineet Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vineet-laboratories-ltd-fallingrising-3779374",
        "imagepath": "",
        "date": "2026-01-03 01:58:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>The stock has underperformed significantly in the short term, falling by 9.43% over the past week while the Sensex gained 0.85%. Despite a positive one-month return of 16.34%, the stock’s year-to-date performance remains negative at -6.64%, contrasting with the Sensex’s modest 0.64% gain. Over the last year, Vineet Laboratories has declined by 16.61%, whereas the Sensex has risen by 7.28%, highlighting the stock’s persistent underperformance relative to the broader market.</p>\n<p>On the day in question, the stock underperformed its sector by 4.76%, marking the seventh consecutive day of losses and a cumulative decline of 13.13% during this period. Intraday, the share price touched a low of ₹33.74, down 5.68%, with heavier trading v..."
      },
      {
        "title": "Vineet Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Mixed Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laboratories-downgraded-to-strong-sell-amid-weak-fundamentals-and-mixed-technicals-3774483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VineetLaborator_mojoScore_3774483.png",
        "date": "2025-12-30 08:58:20",
        "description": "Vineet Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 29 Dec 2025. This shift reflects deteriorating financial fundamentals, subdued valuation appeal, and a complex technical outlook, despite some mildly bullish signals. The company’s recent performance and market trends highlight significant challenges ahead for investors."
      },
      {
        "title": "Vineet Laboratories Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laboratories-stock-rating-upgraded-to-sell-amid-mixed-technical-signals-and-weak-fundamentals-3768921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VineetLaborator_mojoScore_3768921.png",
        "date": "2025-12-25 08:16:47",
        "description": "Vineet Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical indicators and fundamental financial data. Despite ongoing challenges in profitability and sales, recent technical trends suggest a more optimistic market outlook, prompting a reassessment of the company’s investment profile."
      },
      {
        "title": "Vineet Laborator Sees Revision in Market Assessment Amid Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laborator-downgraded-to-strong-sell-amid-weak-fundamentals-and-declining-promoter-confidence-3750035",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VineetLaborator_mojoScore_3750035.png",
        "date": "2025-12-07 10:10:30",
        "description": "Vineet Laborator, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting ongoing challenges in its financial and operational metrics. The recent shift in evaluation metrics highlights concerns across quality, valuation, financial trends, and technical outlook, underscoring the complexities facing the company in a competitive industry environment."
      },
      {
        "title": "Why is Vineet Laborator falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vineet-laborator-fallingrising-3713385",
        "imagepath": "",
        "date": "2025-11-18 23:36:37",
        "description": "As of 18-Nov, Vineet Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 41.23, reflecting a decrease of Rs 1.07 or 2.53%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 10.27% during this period. Additionally, the stock has shown a significant underperformance compared to the sector, with a daily performance lagging by 1.91%. Over the past year, the stock has generated negative returns of 16.11%, contrasting sharply with the Sensex, which has increased by 9.48%. The company's weak long-term fundamentals, highlighted by a staggering -230.87% CAGR growth in operating profits over the last five years and a high Debt to EBITDA ratio of 10.01 times, further contribute to the negative sentiment surrounding the stock. The promoters' reduced stake by 13.37% in the last quarter also signals a lack of confidence in th..."
      },
      {
        "title": "Why is Vineet Laborator falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vineet-laborator-fallingrising-3702743",
        "imagepath": "",
        "date": "2025-11-14 23:31:34",
        "description": "As of 14-Nov, Vineet Laboratories Ltd is experiencing a decline in its stock price, currently at 43.43, which reflects a decrease of 0.39 or 0.89%. The stock has been underperforming, having fallen consecutively for the last two days with a total return of -5.48% during this period. Additionally, the stock's performance today has underperformed its sector by 1.26%. In terms of returns compared to benchmarks, the stock has shown a significant decline of 30.34% year-to-date and 22.45% over the past year, while the Sensex has increased by 8.22% and 9.00% respectively. The stock's delivery volume has also decreased by 7.37% against the 5-day average, indicating falling investor participation.\n\nBroader Market Context: In the short term, Vineet Laboratories Ltd has underperformed compared to the Sensex, which has gained 1.62% over the past week while the stock has dropped by 5.34%. This stark contrast highlights ..."
      },
      {
        "title": "How has been the historical performance of Vineet Laborator?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-vineet-laborator-3683733",
        "imagepath": "",
        "date": "2025-11-09 22:48:55",
        "description": "Answer:\nThe historical performance of Vineet Laborator shows a significant decline in key financial metrics over the past few years, culminating in a challenging fiscal year ending March 2025.\n\nBreakdown:\nVineet Laborator's net sales have decreased from 243.48 Cr in March 2021 to just 75.00 Cr in March 2025, reflecting a downward trend in revenue. The total operating income followed a similar pattern, dropping from 243.48 Cr in March 2021 to 75.00 Cr in March 2025. The company's total expenditure, excluding depreciation, also decreased from 235.33 Cr in March 2021 to 91.28 Cr in March 2025, yet the operating profit (PBDIT) turned negative, showing a loss of 16.28 Cr in March 2025 compared to a profit of 8.15 Cr in March 2021. This resulted in a profit before tax of -20.78 Cr in March 2025, down from 4.06 Cr in March 2021, and a profit after tax of -20.19 Cr, contrasting with a profit of 1.78 Cr in March 202..."
      },
      {
        "title": "Are Vineet Laborator latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-vineet-laborator-latest-results-good-or-bad-3683340",
        "imagepath": "",
        "date": "2025-11-09 19:16:08",
        "description": "The latest financial results for Vineet Laboratories present a mixed picture, highlighting both operational challenges and some positive developments. In the second quarter of FY26, the company reported a net profit of ₹0.40 crores, a notable turnaround from a loss of ₹0.87 crores in the previous quarter. This improvement in profitability is encouraging; however, it comes against a backdrop of declining revenues, with net sales of ₹17.42 crores reflecting an 8.12% decrease year-on-year.\n\nThe operating margin showed significant improvement, rising to 18.25% from 4.30% in the prior quarter, indicating enhanced operational efficiency. Additionally, the profit after tax (PAT) margin also improved to 2.30%, up from a negative margin in the previous quarter. These margin expansions suggest that cost management strategies may be yielding results, although they are primarily driven by cost compression rather than r..."
      },
      {
        "title": "Vineet Laboratories Q2 FY26: Profitability Returns But Revenue Concerns Persist",
        "link": "https://www.marketsmojo.com/news/result-analysis/vineet-laboratories-q2-fy26-profitability-returns-but-revenue-concerns-persist-3682544",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VineetLaborator_quaterlyResult_3682544.png",
        "date": "2025-11-08 20:03:24",
        "description": "Vineet Laboratories Ltd., a micro-cap pharmaceutical intermediates manufacturer, posted a net profit of ₹0.40 crores in Q2 FY26, marking a dramatic turnaround from the ₹0.87 crores loss recorded in the previous quarter. However, the profitability recovery was overshadowed by persistent revenue challenges, with net sales declining 8.12% year-on-year to ₹17.42 crores, raising questions about the sustainability of this turnaround."
      }
    ],
    "total": 272,
    "sid": "1003496",
    "stock_news_url": "https://www.marketsmojo.com/news/vineet-laboratories-1003496"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vineet Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 22",
          "dt": "2022-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Vineet Laboratories Ltd has announced <strong>13:12</strong> rights issue, ex-date: 23 Dec 25",
          "dt": "2025-12-23",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Why is Vineet Laboratories Ltd falling/rising?

2026-01-03 01:58:17

Recent Price Movement and Market Performance

The stock has underperformed significantly in the short term, falling by 9.43% over the past week while the Sensex gained 0.85%. Despite a positive one-month return of 16.34%, the stock’s year-to-date performance remains negative at -6.64%, contrasting with the Sensex’s modest 0.64% gain. Over the last year, Vineet Laboratories has declined by 16.61%, whereas the Sensex has risen by 7.28%, highlighting the stock’s persistent underperformance relative to the broader market.

On the day in question, the stock underperformed its sector by 4.76%, marking the seventh consecutive day of losses and a cumulative decline of 13.13% during this period. Intraday, the share price touched a low of ₹33.74, down 5.68%, with heavier trading v...

Read full news article

Vineet Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Mixed Technicals

2025-12-30 08:58:20

Vineet Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 29 Dec 2025. This shift reflects deteriorating financial fundamentals, subdued valuation appeal, and a complex technical outlook, despite some mildly bullish signals. The company’s recent performance and market trends highlight significant challenges ahead for investors.

Read full news article

Vineet Laboratories Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-12-25 08:16:47

Vineet Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical indicators and fundamental financial data. Despite ongoing challenges in profitability and sales, recent technical trends suggest a more optimistic market outlook, prompting a reassessment of the company’s investment profile.

Read full news article

Vineet Laborator Sees Revision in Market Assessment Amid Challenging Fundamentals

2025-12-07 10:10:30

Vineet Laborator, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting ongoing challenges in its financial and operational metrics. The recent shift in evaluation metrics highlights concerns across quality, valuation, financial trends, and technical outlook, underscoring the complexities facing the company in a competitive industry environment.

Read full news article

Why is Vineet Laborator falling/rising?

2025-11-18 23:36:37

As of 18-Nov, Vineet Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 41.23, reflecting a decrease of Rs 1.07 or 2.53%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 10.27% during this period. Additionally, the stock has shown a significant underperformance compared to the sector, with a daily performance lagging by 1.91%. Over the past year, the stock has generated negative returns of 16.11%, contrasting sharply with the Sensex, which has increased by 9.48%. The company's weak long-term fundamentals, highlighted by a staggering -230.87% CAGR growth in operating profits over the last five years and a high Debt to EBITDA ratio of 10.01 times, further contribute to the negative sentiment surrounding the stock. The promoters' reduced stake by 13.37% in the last quarter also signals a lack of confidence in th...

Read full news article

Why is Vineet Laborator falling/rising?

2025-11-14 23:31:34

As of 14-Nov, Vineet Laboratories Ltd is experiencing a decline in its stock price, currently at 43.43, which reflects a decrease of 0.39 or 0.89%. The stock has been underperforming, having fallen consecutively for the last two days with a total return of -5.48% during this period. Additionally, the stock's performance today has underperformed its sector by 1.26%. In terms of returns compared to benchmarks, the stock has shown a significant decline of 30.34% year-to-date and 22.45% over the past year, while the Sensex has increased by 8.22% and 9.00% respectively. The stock's delivery volume has also decreased by 7.37% against the 5-day average, indicating falling investor participation. Broader Market Context: In the short term, Vineet Laboratories Ltd has underperformed compared to the Sensex, which has gained 1.62% over the past week while the stock has dropped by 5.34%. This stark contrast highlights ...

Read full news article

How has been the historical performance of Vineet Laborator?

2025-11-09 22:48:55

Answer: The historical performance of Vineet Laborator shows a significant decline in key financial metrics over the past few years, culminating in a challenging fiscal year ending March 2025. Breakdown: Vineet Laborator's net sales have decreased from 243.48 Cr in March 2021 to just 75.00 Cr in March 2025, reflecting a downward trend in revenue. The total operating income followed a similar pattern, dropping from 243.48 Cr in March 2021 to 75.00 Cr in March 2025. The company's total expenditure, excluding depreciation, also decreased from 235.33 Cr in March 2021 to 91.28 Cr in March 2025, yet the operating profit (PBDIT) turned negative, showing a loss of 16.28 Cr in March 2025 compared to a profit of 8.15 Cr in March 2021. This resulted in a profit before tax of -20.78 Cr in March 2025, down from 4.06 Cr in March 2021, and a profit after tax of -20.19 Cr, contrasting with a profit of 1.78 Cr in March 202...

Read full news article

Are Vineet Laborator latest results good or bad?

2025-11-09 19:16:08

The latest financial results for Vineet Laboratories present a mixed picture, highlighting both operational challenges and some positive developments. In the second quarter of FY26, the company reported a net profit of ₹0.40 crores, a notable turnaround from a loss of ₹0.87 crores in the previous quarter. This improvement in profitability is encouraging; however, it comes against a backdrop of declining revenues, with net sales of ₹17.42 crores reflecting an 8.12% decrease year-on-year. The operating margin showed significant improvement, rising to 18.25% from 4.30% in the prior quarter, indicating enhanced operational efficiency. Additionally, the profit after tax (PAT) margin also improved to 2.30%, up from a negative margin in the previous quarter. These margin expansions suggest that cost management strategies may be yielding results, although they are primarily driven by cost compression rather than r...

Read full news article

Vineet Laboratories Q2 FY26: Profitability Returns But Revenue Concerns Persist

2025-11-08 20:03:24

Vineet Laboratories Ltd., a micro-cap pharmaceutical intermediates manufacturer, posted a net profit of ₹0.40 crores in Q2 FY26, marking a dramatic turnaround from the ₹0.87 crores loss recorded in the previous quarter. However, the profitability recovery was overshadowed by persistent revenue challenges, with net sales declining 8.12% year-on-year to ₹17.42 crores, raising questions about the sustainability of this turnaround.

Read full news article

View All News